VIANEX S.A. is a prominent Greek pharmaceutical company and is regarded as one of the largest forces in the Greek pharmaceutical industry. The company was officially founded in 1971 by the Giannakopoulos family, building upon a pharmaceutical industry involvement that dates back to 1924. Its headquarters are located in Athens, Greece, and the company operates four state-of-the-art manufacturing plants, with three in the Attica region and one in Patras. VIANEX employs a workforce of over 1,300 people and has an annual production volume exceeding 121 million units.
Core Business and Activities
The core business of VIANEX S.A. encompasses a wide range of activities within the pharmaceutical sector, from research and development to manufacturing, trade, and global distribution. The company???s activities include:
Production and Manufacturing: VIANEX produces a large volume of pharmaceuticals, utilising its four specialised manufacturing facilities to create all pharmaceutical forms. It is a major Manufacturer/Innovator and also offers services as a Contract Development and Manufacturing Organisation (CDMO) and a Contract Manufacturing Organisation (CMO) for third parties.
Import, Marketing, and Distribution: The company is active in the exclusive import, packaging, marketing, and distribution of a large number of pharmaceuticals across all various therapeutic classes within the Greek market.
International Trade and Export: VIANEX has an extensive international presence, exporting registered products to over 35 countries, including major markets in Europe (like the UK, France, Spain, Germany, and Denmark), the Middle East (such as Jordan and Saudi Arabia), Africa (including Tunisia and South Africa), and Asia (including the Philippines and Japan). Overall, it boasts more than 100 international partnerships and exports to 114 countries.
Research & Development (R&D): VIANEX S.A. maintains its own dedicated Research & Development department. This department focuses on the development of new pharmaceutical formulations, the creation of new pharmaceutical forms, and the continual improvement of manufacturing and storage methods. The company also collaborates with university clinics and research centres to advance scientific knowledge and integrate research findings into its production processes.
Products and Services Offered
Pharmaceutical Products
VIANEX???s product portfolio is comprehensive, covering a broad spectrum of medical needs. The company handles both Prescription (RX) and Over-the-Counter (O.T.C.) products.
Prescription (RX) Therapeutic Classes include:
* Gastroenterology
* Cardiovascular (e.g., Hypertension, Cholesterol)
* Central Nervous System/Neurology/Psychiatry
* Anti-infective drugs and Antibiotics
* Oncology
* Vaccines and Blood derivatives
* Dermatological
* Osteoporosis
* Anti-inflammatories
* Urology, Gynaecology, and Obstetrics
* Asthma
* Eye care (Ophthalmology)
* Metabolism, Nutrition, and Alimentary systems preparations.
* Specific chemical categories such as Barbiturates, sulphonamides, glycosides, and alkaloids.
Other Products and Categories:
* Over-the-Counter (O.T.C.) pharmaceutical and non-pharmaceutical products, distributed through its subsidiary VIAN S.A.
* Nutritional Supplements and Vitamins, such as the Altion brand.
* Cosmetics and Medicated Products.
* Finished Dosage Forms including Injectables.
* Health and Diet products.
Services
In addition to its own product development and distribution, VIANEX offers a range of services to other pharmaceutical entities:
Contract Development and Manufacturing (CDMO/CMO): Provides manufacturing services for third parties.
Contract Manufacturing and Lyophilisation (freeze-drying) services.
Development of New Pharmaceutical Forms for external partners.
Import, Representation, and Distribution for international pharmaceutical companies, facilitating their entry and market presence in Greece. The company maintains strategic alliances with global pharmaceutical entities, including Merck & Co. (U.S.A.), Sanofi Pasteur MSD (France), and Takeda Pharmaceutical Company Limited (Japan).
Trade, Export, and Distribution services on a global scale.
Global Recognition and Partnerships
VIANEX S.A. operates with a commitment to high international standards, which is supported by its state-of-the-art facilities and rigorous quality control processes. This dedication has led to its approval as a supplier by the World Health Organization (WHO) since 2011, further cementing its role as a globally recognized manufacturer and supplier of pharmaceutical products.
Please note: This information is generated by AI. For legal use, verify with company sources.
